Table 1 Summary of patient characteristics (mean ± SE)
RA (n = 23) | OA (n = 16) | Healthy control (n = 7) | |
|---|---|---|---|
Age | 56.6 ± 3.4 | 64.2 ± 6.2 | 46 ± 4.6 |
Female, n (%) | 17 (74) | 13 (81) | 3 (43) |
Methotrexate dose (mg/week) | 7.9 ± 1.2 | ||
Glucocorticoid dose (mg/day) | 1.33 ± 0.5 | ||
DAS28 (ESR) | 4.81 ± 0.3 | ||
Duration (years) | 5.2 ± 1.0 | ||
RF positive (%) | 78.3 | ||
ACPA positive (%) | 65.2 | ||
Stage (I/II/III/IV) | (7/8/4/4) | ||
Number of previous biologics | 1.0 ± 0.3 |